Saturday, June 10, 2023 9:20:13 PM
If I was a chart guy I’d be looking at the left side of the chart and ask why the right side isn’t a mirror image. If you look up until 2020 it looks pretty symmetric right? So what happened?; ). I think plans changed to start looking at a bigger picture that was going to take more time to prepare for. Seems to be just after data lock and Flaskworks at the time that NWBO would have been given the data that the chart started shifting first sideways then down. Somebody seemed to understand that more time might be needed but the amount of time seemed uncertain so the drift then gradual down slope to the lowest and slowest uptrend which was rushed there by May 10th last year. Was tissue agnostic designation being discussed with regulators back in 2020-2021?; ).
The correction back up should take the chart up to $11 and beyond fairly quickly because the delay for everyone to get on board very likely has not been in vain but in preparation. NWBO is talking like DCVax is for more than just brain tumors. Have regulators been saying the same thing?; ). Did regulators want the bigger boat because they could see where the demand would be coming from and didn’t want to get caught in the middle of a stampede?; ). I don’t think Dr. Linda Liau just skips town for no reason when something important is about to be shared. Best wishes.
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM